Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
22
NCT04262336
Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 21, 2020
Completion: May 23, 2023